CH
MRNA icon

Cromwell Holdings’s Moderna MRNA Stock Holding History

Cromwell Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.2K Buy
1,259
+51
+4% +$2.64K 0.04% 379
2026
Q1 		$61.4K Buy
1,208
+8
+0.7% +$373 0.03% 437
2025
Q4 		$35.4K Buy
1,200
+341
+40% +$9.26K 0.02% 516
2025
Q3 		$22.2K Sell
859
-319
-27% -$8.9K 0.01% 572
2025
Q2 		$32.5K Buy
+1,178
New +$31K 0.02% 524
2025
Q1 		– Sell
-316
Closed -$13.1K – 825
2024
Q4 		$13.1K Buy
+316
New +$15.1K 0.01% 593
2024
Q3 		– Sell
-1,021
Closed -$121K – 625
2024
Q2 		$121K Buy
+1,021
New +$129K 0.07% 237

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Cromwell Holdings's MRNA Position: Q2 2026 in Review

Cromwell Holdings increased its Moderna (MRNA) stake by 4.2% in Q2 2026, buying an estimated $2.64K and bringing the position to 1,259 shares worth $88.2K. The position accounts for 0.04% of the portfolio, ranked #379.

Cromwell Holdings first reported a position in MRNA in Q2 2024 and has held it in 7 quarters since. The position peaked at $121K in Q2 2024. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Cromwell Holdings held 1,259 shares of Moderna worth $88.2K as of Q2 2026.
  • Cromwell Holdings bought 51 Moderna shares in Q2 2026, an estimated $2.64K.
  • Moderna made up 0.04% of Cromwell Holdings's portfolio in Q2 2026, its #379 holding.
  • Cromwell Holdings first reported a position in Moderna in Q2 2024 and has held it in 7 quarters since.
  • Cromwell Holdings's Moderna position peaked at $121K in Q2 2024.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.